VIROSTATICS srl

Respiratory Syncytial Virus (RSV) is a seasonal virus causing acute respiratory tract infections in infants and older adults. Last year there has been a significant rise in RSV cases.
At ViroStatics, we can assess and demonstrate the efficacy of your device against RSV. We have developed an advanced experimental system to evaluate the ability of any device to eliminate respiratory viruses (such as RSV, Covid-19, influenza virus, avian flu) in aerosol, the main form of transmission of these pathogens.
Schedule a call with us to learn more, d.deforni@virostatics.com

ViroStatics stays committed to tackle viruses causing severe respiratory diseases.

By employing real wild-type viruses not surrogate viruses, we offer validated assays to advance your Research, enabling you testing any solution for virucidal activity against viruses in their most relevant transmission milieu. Available strains include influenza A/B, respiratory syncytial virus (RSV), SARS‑CoV‑2 (all variants). 

Learn more about our innovative aerosol testing technology to determine the virucidal activity of your products, whether they are small molecules, disinfectants or devices for disinfection or sanitisation of air or surfaces. Contact us to request a quote -> d.deforni@virostatics.com